Primary Site >> Stomach Cancer
Gene >> LGALS3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Expression of a 31-kDa lactoside-binding lectin in normal human gastric mucosa and in primary and metastatic gastric carcinomas. PMID: 8112883 |
Ref: Increased galectin-3 expression in gastric cancer: correlations with histopathological subtypes, galactosylated antigens and tumor cell proliferation. PMID: 10940822 |
Ref: Immunohistochemical detection of galectin-3 in canine gastric carcinomas. PMID: 11222020 |
Ref: Role of elastin-matrix interactions in tumor progression. PMID: 12083851 Ref: Increased expression of galectin-3 in primary gastric cancer and the metastatic lymph nodes. PMID: 12375039 |
Ref: Expression of liver-intestine cadherin and its possible interaction with galectin-3 in ductal adenocarcinoma of the pancreas. PMID: 12824888 |
Ref: [Study on association between the expression of galectin- 3 and the peritoneal metastasis in gastric cancer]. PMID: 16155829 |
Ref: [Expression of galectin-3 mRNA in gastric cancer with peritoneal metastasis]. PMID: 16468655 Ref: Reduced galectin-3 expression is an indicator of unfavorable prognosis in gastric cancer. PMID: 16619546 |
Ref: Li-cadherin is inversely correlated with galectin-3 expression in gastric cancer. PMID: 17999183 |
Ref: [Expression of galectin 3 and Sambucus nigra agglutinin and their clinicopathological significance in benign and malignant lesions of stomach]. PMID: 19434543 Ref: [Study on the expression and significance of Galectin-3 and CDC25B mRNA in human gastric carcinoma]. PMID: 19504441 |
Ref: Galectin-3 increases gastric cancer cell motility by up-regulating fascin-1 expression. PMID: 19818782 Ref: Silencing of galectin-3 changes the gene expression and augments the sensitivity of gastric cancer cells to chemotherapeutic agents. PMID: 19843071 |
Ref: Galectin-3 germline variant at position 191 enhances nuclear accumulation and activation of beta-catenin in gastric cancer. PMID: 21750908 Ref: Galectin-3 facilitates cell motility in gastric cancer by up-regulating protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1). PMID: 21966428 |
Ref: Fascin expression is related to poor survival in gastric cancer. PMID: 23252866 |
Ref: Protein expression status in mucosal and submucosal portions of early gastric cancers and their predictive value for lymph node metastasis. PMID: 23758612 |
Ref: Up-regulation of neogenin-1 increases cell proliferation and motility in gastric cancer. PMID: 24930499 Ref: Ablation of galectin-3 induces p27(KIP1)-dependent premature senescence without oncogenic stress. PMID: 24971481 |
Ref: Deregulated expression of annexin-A2 and galectin-3 is associated with metastasis in gastric cancer patients. PMID: 25034653 Ref: Serum galectin-3 as a potential marker for gastric cancer. PMID: 25765552 |
Ref: Clinical Significance of Serum Galectin-3 Levels in Gastric Cancer Patients. PMID: 27038444 Ref: Ablation of human telomerase reverse transcriptase (hTERT) induces cellular senescence in gastric cancer through a galectin-3 dependent mechanism. PMID: 27494887 Ref: O-glycan sialylation alters galectin-3 subcellular localization and decreases chemotherapy sensitivity in gastric cancer. PMID: 27835877 |
Ref: SCHLAFEN 5 expression correlates with intestinal metaplasia that progresses to gastric cancer. PMID: 27032393 Ref: Pectic Oligosaccharide from tomato exhibiting anticancer potential on a gastric cancer cell line: Structure-function relationship. PMID: 28115100 Ref: Galectin-3 rs4652 A>C polymorphism is associated with the risk of gastric carcinoma and P-glycoprotein expression level. PMID: 29250191 |
Ref: Clinical characteristics and prognostic significance of galectins for patients with gastric cancer: A meta-analysis. PMID: 29940258 |